Wolverine Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Wolverine Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-61,661	Closed	-$2.05M	–	2374
2022 Q4	$2.05M	Buy	61,661 +36,445	+145%	+$1.17M	0.02%	559
2022 Q3	$795K	Buy	+25,216	New	+$817K	0.01%	858

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Asset Management's VIVO Position: Q1 2023 in Review

Wolverine Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 61,661 shares — an estimated $2.05M sold.

Wolverine Asset Management first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $2.05M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Wolverine Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 61,661 Meridian Bioscience Inc shares in Q1 2023, an estimated $2.05M.
Wolverine Asset Management first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Wolverine Asset Management's Meridian Bioscience Inc position peaked at $2.05M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.